NEMERA offers off-the-shelf nasal spray devices with in-vitro bioequivalence (IVBE) performanceApril 10, 2018
NEMERA offers off-the-shelf nasal spray devices with in-vitro bioequivalence (IVBE) performance
Nemera has developed customized delivery systems with in-vitro bioequivalence performance for the following drugs:
Those customized devices are based on SP270+ pump platform technology, and Nemera has performed a comparative analysis and related use human factor studies.
- SP270+ pumps
- Nasal actuator
Example of SP270+ crimp-on (20mm) and nasal actuator, a reference in consistency and reliability
With spray expertise, regulatory experts and laboratory testing capabilities, Nemera is able to support your development by performing screening testing with your formulation following the EMA and FDA requirements.
For further information about the Nemera Device Equivalence program,
please contact us at: firstname.lastname@example.org